Management of attention-deficit hyperactivity disorder

Attention-deficit hyperactivity disorder (ADHD/ADD) is a neurobehavioral disorder of childhood onset characterized by severe, developmentally inappropriate motor hyperactivity, inattention, and impulsiveness that result in impairment in more than one setting. It affects the home, school, and communi...

Full description

Bibliographic Details
Main Authors: Verma, Rohit, Balhara, Yatan Pal Singh, Mathur, Shachi
Format: Online
Language:English
Published: Medknow Publications 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173906/
id pubmed-3173906
recordtype oai_dc
spelling pubmed-31739062011-10-04 Management of attention-deficit hyperactivity disorder Verma, Rohit Balhara, Yatan Pal Singh Mathur, Shachi Review Article Attention-deficit hyperactivity disorder (ADHD/ADD) is a neurobehavioral disorder of childhood onset characterized by severe, developmentally inappropriate motor hyperactivity, inattention, and impulsiveness that result in impairment in more than one setting. It affects the home, school, and community life of 39% of school-going children worldwide. There is increasing recognition that ADHD symptoms and clinically defined disorder can persist into adult life and are associated with later drug and alcohol misuse and social and work difficulties. Added to that is the extreme variability of the disorder over time, within the same individual, between individuals, and across different circumstances. Treatment with stimulants and nonstimulants has proven effective in different subgroups, with the effectiveness of specific agents most likely related to the primary neurotransmitter involved. However, stimulants with a short duration of action have been problematic for some patients. Parent training and cognitive behavioral therapies represent the most widely adjunct psychosocial interventions to pharmacotherapy. Medknow Publications 2011 /pmc/articles/PMC3173906/ /pubmed/21977081 http://dx.doi.org/10.4103/1817-1745.84400 Text en © Journal of Pediatric Neurosciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Verma, Rohit
Balhara, Yatan Pal Singh
Mathur, Shachi
spellingShingle Verma, Rohit
Balhara, Yatan Pal Singh
Mathur, Shachi
Management of attention-deficit hyperactivity disorder
author_facet Verma, Rohit
Balhara, Yatan Pal Singh
Mathur, Shachi
author_sort Verma, Rohit
title Management of attention-deficit hyperactivity disorder
title_short Management of attention-deficit hyperactivity disorder
title_full Management of attention-deficit hyperactivity disorder
title_fullStr Management of attention-deficit hyperactivity disorder
title_full_unstemmed Management of attention-deficit hyperactivity disorder
title_sort management of attention-deficit hyperactivity disorder
description Attention-deficit hyperactivity disorder (ADHD/ADD) is a neurobehavioral disorder of childhood onset characterized by severe, developmentally inappropriate motor hyperactivity, inattention, and impulsiveness that result in impairment in more than one setting. It affects the home, school, and community life of 39% of school-going children worldwide. There is increasing recognition that ADHD symptoms and clinically defined disorder can persist into adult life and are associated with later drug and alcohol misuse and social and work difficulties. Added to that is the extreme variability of the disorder over time, within the same individual, between individuals, and across different circumstances. Treatment with stimulants and nonstimulants has proven effective in different subgroups, with the effectiveness of specific agents most likely related to the primary neurotransmitter involved. However, stimulants with a short duration of action have been problematic for some patients. Parent training and cognitive behavioral therapies represent the most widely adjunct psychosocial interventions to pharmacotherapy.
publisher Medknow Publications
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3173906/
_version_ 1611475826672402432